Skip to content
Trial Eligibility
Menu

NYSCF Scientific Discovery Biobank

NCT06203106

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for the major diseases of our time.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • ALS
  • Amyotrophic Lateral Sclerosis
  • Alzheimer Disease
  • Alzheimer Disease, Early Onset
  • Alzheimer Disease, Late Onset
  • Batten Disease
  • Corticobasal Degeneration
  • Dementia
  • Frontotemporal Dementia
  • Huntington Disease
  • Lewy Body Disease
  • Multiple Sclerosis
  • Multiple System Atrophy
  • Parkinson Disease
  • Parkinson's Disease and Parkinsonism
  • Progressive Supranuclear Palsy
  • INAD
  • Diabetes
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1
  • Macular Degeneration
  • Ovarian Cancer
  • Cervical Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer
  • PTSD
  • Post Traumatic Stress Disorder

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
30 days and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
New York Stem Cell Foundation Research Institute
Last updated on ClinicalTrials.gov
March 3, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • New York Stem Cell Foundation Research Institute · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.